Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PASG compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
PASG
Passage BIO, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
PASG
Passage BIO, Inc.
Change
3.44
▲
+3.61%
Mkt cap
$10.7M
Revenue
$99,000
Q3 FY24
Revenue
—
AMGN
Amgen Inc
Change
462.39
▼
−0.66%
Regular session
Nov 3 '26
Mkt cap
$251.6B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Regular session
Nov 3 '26
PASG
Passage BIO, Inc.
vs
AMGN
Amgen Inc
3.44
▲
+3.61%
Price
462.39
▼
−0.66%
$10.7M
Mkt cap
$251.6B
Q3 FY24
$99,000
Revenue
$10.1B
Q2 FY26
—
Revenue
$36.8B
FY25
Change
Change
PASG
3.44
▲
+3.61%
vs
AMGN
462.39
▼
−0.66%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PASG: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PASG
1
—
Gemma
unlisted
supplier
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PASG, solid
AMGN, dashed